Tumour infiltrating lymphocytes in relation to tumour angiogenesis, apoptosis and prognosis in patients with large cell lung carcinoma

被引:42
作者
Eerola, AK
Soini, Y
Pääkkö, P
机构
[1] Univ Oulu, Dept Pathol, FIN-90401 Oulu, Finland
[2] Oulu Univ Hosp, FIN-90401 Oulu, Finland
关键词
large cell lung carcinoma (LCLC); large cell neuroendocrine carcinoma (LCNEC); tumour infiltrating lymphocytes (TILs); apoptosis; microvessel density (MD); prognosis;
D O I
10.1016/S0169-5002(99)00072-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune escape of tumour infiltrating lymphocytes (TILs), angiogenesis and apoptosis are important factors that contribute to tumour growth. In the present study immunohistochemical methods were used to investigate the relationships of these factors and their role in the prognosis of 38 patients operated on for a large cell lung carcinoma (LCLC). T cells and macrophages were most commonly found TILs in LCLC while the number of intratumoural B cells was small. A high number of intratumoural macrophages associated with angiogenesis, as measured by microvessel density (MD). TILs were not associated with the extent of apoptosis in LCLC, as measured by in situ 3'-end labelling of apoptotic DNA. The high number of intratumoural macrophages and B cells was a prognostic marker showing a better survival time of the patients with LCLC. Furthermore, a high number of inratumoural macrohages was significantly associated with longer disease free survival and low tumour stage of the patients with LCLC. A high number of intratumoural B cells and macrophages was associated with a small tumour size suggesting that both B cells and macrophages are important TILs limiting the growth of LCLC. Instead, T cells were not associated with survival or with the size or stage of the tumour suggesting that cytotoxic T cells are less important mediators of tumour host interaction in LCLC than B cells and macrophages. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:73 / 83
页数:11
相关论文
共 50 条
[1]  
BALCH CM, 1990, ARCH SURG-CHICAGO, V125, P200
[2]   APOPTOSIS AND DISEASE [J].
CARSON, DA ;
RIBEIRO, JM .
LANCET, 1993, 341 (8855) :1251-1254
[3]  
CLAASEN HHV, 1992, LAB INVEST, V67, P166
[4]   CONTROL OF ANGIOGENESIS IN FIBROBLASTS BY P53 REGULATION OF THROMBOSPONDIN-1 [J].
DAMERON, KM ;
VOLPERT, OV ;
TAINSKY, MA ;
BOUCK, N .
SCIENCE, 1994, 265 (5178) :1582-1584
[5]   LARGE CELL-CARCINOMA OF THE LUNG - A HIGHLY AGGRESSIVE TUMOR WITH DISMAL PROGNOSIS [J].
DOWNEY, RS ;
SEWELL, CW ;
MANSOUR, KA .
ANNALS OF THORACIC SURGERY, 1989, 47 (06) :806-808
[6]  
Eerola AK, 1997, J PATHOL, V181, P172
[7]  
Ekert PG, 1997, BRIT MED BULL, V53, P591
[8]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[9]   Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression [J].
Fontanini, G ;
Vignati, S ;
Lucchi, M ;
Mussi, A ;
Calcinai, A ;
Boldrini, L ;
Chine, S ;
Silvestri, V ;
Angeletti, CA ;
Basolo, F ;
Bevilacqua, G .
BRITISH JOURNAL OF CANCER, 1997, 75 (09) :1295-1301
[10]   USEFULNESS OF GLYCOSYLATED RECOMBINANT HUMAN LYMPHOTOXIN FOR GROWTH-INHIBITION OF HUMAN AND MURINE SOLID TUMORS AND EXPERIMENTAL METASTASIS IN MICE [J].
FUNAHASHI, I ;
KAWATSU, M ;
KAJIKAWA, T ;
TAKEO, K ;
ASAHI, T ;
KAKUTANI, T ;
YAMASHITA, T ;
KAWAHARADA, H ;
WATANABE, K .
JOURNAL OF IMMUNOTHERAPY, 1991, 10 (01) :28-38